Skip to main content
Egyptian Rheumatology and Rehabilitation

Table 5 aPLs and survival in COVID-19 patients with thrombotic events

From: Anti-phospholipid antibodies in the setting of thromboembolic events associated with severe COVID-19 pneumonia

Positive aPLs

Survived(n = 47)

Died(n = 18)

P

LAC

19(40.4)

11(61.1)

0.1342

aCL IgG

aCL IgM

6(12.8)

3(6.4)

4(22.2)

1(5.6)

0.4452

1.0002

aβ2GPI IgG

aβ2GPI IgM

8(17.0)

5(10.6)

2(11.1)

1(5.6)

0.7132

1.0002

  1. aPLs anti-phospholipid antibodies, LAC lupus anti-coagulant, aCL anti-cardiolipin, aβ2GPI anti-β2 glycoprotein, data are expressed as no. (%)
  2. 2Chi square test
Back to article page